0001209191-17-037322.txt : 20170602 0001209191-17-037322.hdr.sgml : 20170602 20170602164329 ACCESSION NUMBER: 0001209191-17-037322 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170213 FILED AS OF DATE: 20170602 DATE AS OF CHANGE: 20170602 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDNAX, INC. CENTRAL INDEX KEY: 0000893949 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOSPITALS [8060] IRS NUMBER: 263667538 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1301 CONCORD TERRACE CITY: SUNRISE STATE: FL ZIP: 33323 BUSINESS PHONE: 9543840175 MAIL ADDRESS: STREET 1: 1301 CONCORD TERRACE CITY: SUNRISE STATE: FL ZIP: 33323 FORMER COMPANY: FORMER CONFORMED NAME: PEDIATRIX MEDICAL GROUP INC DATE OF NAME CHANGE: 19950801 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MEDEL ROGER MD CENTRAL INDEX KEY: 0001093125 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12111 FILM NUMBER: 17888608 MAIL ADDRESS: STREET 1: 1455 NORTH PARK DRIVE CITY: FORT LAUDERDALE STATE: FL ZIP: 33326 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-02-13 0 0000893949 MEDNAX, INC. MD 0001093125 MEDEL ROGER MD 1301 CONCORD TERRACE SUNRISE FL 33323 1 1 0 0 Chief Executive Officer Common Stock 2017-02-13 4 G 0 16020 0.00 D 1233304 D Common Stock 2017-06-01 4 A 0 110532 0.00 A 1343836 D Common Stock 2017-06-01 4 F 0 38257 0.00 D 1288739 D Disposition pursuant to a gift to a charitable institute. Restricted shares granted pursuant to the Issuer's Amended and Restate 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 27,633 additional shares based on the achievement of certain performance-based criteria for the period from April 1, 2017 through March 31, 2018. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will not vest any earlier than in three equal installments on June 1, 2018, June 1, 2019 and June 1, 2020. Reflects a reduction of 16,840 in previously reported target shares that were granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with achievement of specified performance-based criteria below target for the performance period from April 1, 2016 through March 31, 2017. The decrease in restricted shares impacts the installments vesting on June 1, 2017, June 1, 2018 and June 1, 2019. The vesting of such shares remains subject to continued employment. Dominic J. Andreano, Attorney-in-Fact 2017-06-02